http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040061221-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab1c1b70586b15cfa580306f5fcfbc38 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2002-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_161138585be9001307990867de23e412 |
| publicationDate | 2004-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040061221-A |
| titleOfInvention | Human protooncogene hlc-2 and protein encoded therein |
| abstract | The present invention relates to a novel far-oncogene and a protein encoded by the same, wherein the far-oncogene of the present invention has no homology with existing reported far-oncogenes and is a novel gene that exhibits metastasis-inducing ability as leukemia, It can be effectively used for the diagnosis of cancer including uterine cancer, lymphoma, colorectal cancer, lung cancer, skin cancer, etc., production of transgenic animals and anti-sense gene therapy. |
| priorityDate | 2002-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.